Joseph Emil Amegadzie

Joseph received a PhD in Medicine from Memorial University in 2021 with concentrations in Epidemiology/Pharmacoepidemiology study of airway diseases of asthma, COPD and asthma-COPD overlap. Using the United Kingdom’s Clinical Practice Research Datalink of over 250,000 anonymous patient’s data, Joseph investigated gender differences in new-users of inhaled pharmacotherapies and the association between β2-agonist-based medications and safety events for cardio-respiratory outcomes. His current focus is on development and implementation of an agent-based simulation model for COPD, creating, validating, and implementing prediction models that can predict heterogeneity of treatment effect, implementing Artificial Intelligence (AI) and Natural Language Processing (NLP) methods for facilitating the update of clinical prediction models and designing and implementing cloud-based technologies for remote access to clinical prediction models.

EDUCATION:

• PhD Memorial University of Newfoundland
• MSc Kwame Nkrumah University of Science and Technology
• BSc (Hons.) University of Cape Coast